- Report
- January 2025
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- June 2024
- 160 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- June 2024
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 48 Pages
Global
From €3813EUR$3,995USD£3,195GBP
- Report
- December 2022
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- August 2023
- 150 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- February 2024
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- February 2023
- 260 Pages
Global
From €2672EUR$2,800USD£2,239GBP
- Report
- September 2021
- 40 Pages
China
From €2481EUR$2,600USD£2,079GBP
- Report
- August 2022
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Report
- August 2022
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Report
- July 2022
- 131 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- June 2023
- 159 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Drug Pipelines
- January 2023
- 30 Pages
United States
From €2625EUR$2,750USD£2,199GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more